Showing results (1-10 of 4,199) with videos related to

Sort By:
Pageof 420
Discover Oncology|December 8, 2022
SPI1 is a prognostic biomarker of immune infiltration and immunotherapy efficacy in clear cell renal cell carcinomaHuayi Feng, Tao Wang, Jiali Ye, et al.
Discover Oncology|December 9, 2022
USF1-CHCHD4 axis promotes lung adenocarcinoma progression partially via activating the MYC pathwayYuhui Zhou, Yunxia Zhao, Wei Ma, et al.
Discover Oncology|June 29, 2022
CD155 promotes radioresistance and malignancy of esophageal cancer by regulating Hippo-YAP pathwayHuixian Xin, Yuchen Liu, Pengxiang Chen, et al.
Discover Oncology|July 1, 2022
miR-1307-5p suppresses proliferation and tumorigenesis of bladder cancer via targeting MDM4 and the Hippo signaling pathwayWei Huang, Cheng Zhang, Shida Xiong, et al.
Discover Oncology|December 11, 2022
Effect of miR-27b on the proliferation and apoptosis of diffuse large b-cell lymphoma cells by targeting the regulation of MET/PI3K/AKT pathwayRui Zhang, Tianjiao Huang, Jinfeng Li, et al.
Discover Oncology|November 21, 2022
Serum insulin-like growth factor binding protein 3 as a promising diagnostic and prognostic biomarker in esophagogastric junction adenocarcinomaTian-Yan Ding, Yu-Hui Peng, Chao-Qun Hong, et al.
Discover Oncology|January 7, 2023
The impact of postmastectomy radiotherapy on cT1-2N1 breast cancer patients with ypN0 after neoadjuvant chemotherapy: a retrospective study based on real-world dataYuran Dai, Shishi Ma, Ailin Lan, et al.
Discover Oncology|December 29, 2022
Lymphocytes from B-acute lymphoblastic leukemia patients present differential regulation of the adenosinergic axis depending on risk stratificationVitória Brum da Silva Nunes, Camila Kehl Dias, Juliete Nathali Scholl, et al.
Discover Oncology|June 13, 2022
Combining metabolic phenotype determination with metabolomics and transcriptional analyses to reveal pathways regulated by hydroxycarboxylic acid receptor 2Philipp Rabe, Mareike Gehmlich, Anna Peters, et al.
Discover Oncology|June 7, 2022
Apigenin impedes cell cycle progression at G2 phase in prostate cancer cellsSu Su Thae Hnit, Mu Yao, Chanlu Xie, et al.
Pageof 420